Skip to main content

Suicide survey in a London borough

About one million people worldwide die each year from suicide. Hence, strategies to reduce deaths from suicide are a key public health priority in many countries. A recent study by Dennis Ougrin and colleagues published in the Journal of Public Health aimed to collate relevant data from local and national sources, which will demonstrate the incidence of death from suicide and undetermined injury in the London Borough of Brent. The study also aimed to determine the characteristics of the subjects dying of suicide and undetermined injury in the locality and to identify what structures and processes are in place for recognizing, monitoring and sharing information about suicide between primary care, secondary care and public health.

The authors identified all deaths by suicides and open verdicts in the residents of Brent between February 2005 and February 2008. Health records of the identified subjects were analysed by two researchers. The annual rate of suicide in the study period was 6.8 per 100 000 inhabitants. Of the 54 cases of suicide in the , 45% had a psychiatric diagnosis and 18% were in current contact with mental health services. Hanging was the most frequent mode of suicide. Only 25% had seen their general practitioner within a month of suicide.

The study showed that a suicide survey is a feasible method of monitoring suicide, sharing data between key stakeholders and learning from the trends uncovered. The role for primary care in suicide prevention seems important but may be limited by an unexpectedly large proportion of the subjects not being in contact with primary care. In addition, the majority of the last primary care consultations were not for mental health problems This emphasizes the importance of wider societal initiative to improve suicide rates in addition to NHS interventions (e.g. reducing access to methods of suicide; and better employment, education and housing).


Popular posts from this blog

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.60 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What will Brexit mean for the NHS?

On the 29 March 2017, the Prime Minister of the UK Theresa May, formally notified the European Union (EU) Council President, Donald Tusk, of the UK’s intention to leave the EU. Theresa May’s letter to Donald Tusk triggers a two-year process during which the UK will have to negotiate both the terms of its exit from EU and the arrangements that will replace those we have had for over 40 years with the other member states of the EU. The consequences of the United Kingdom’s departure from the EU (commonly referred to as ‘Brexit’) will be wide-ranging and will affect all areas of UK’s society, including the National Health Service (NHS).

For the NHS, Brexit comes at a time when it faces many other major challenges. These include severe financial pressures, rising workload, increased waiting times for both primary care and specialist services, and shortages of health professionals in many key areas (such as in general practice and in emergency departments). The NHS also faces challenges fr…

Dr Demis Hassabis, Co-Founder and CEO of DeepMind, Speaks about AI in Healthcare

On 28 September 2017, I attended the Annual Institute of Global Health Innovation Lecture: Artificial General Intelligence and Healthcare, delivered by Dr Demis Hassabis, co-founder and CEO of Google DeepMind. Artificial intelligence is the science of making machines smart argued Dr Hassabis, so how can we make it improve the healthcare sector? Dr Hassabis then went on to describe the work that DeepMind was carrying out in healthcare in areas such as organising information, deep learning to support the reporting of medical images (such as scans and pathology slides), and biomedical science. Dr Hassabis also discussed the challenges of applying techniques such as reinforcement learning in healthcare. He concluded that artificial intelligence has great scope for improving healthcare; for example, by prioritising the tasks that clinicians had to carry out and by providing decision support aids for both patients and doctors. Dr Hassabis also discussed some of the ethical issues in using …